Cero Therapeutics Holdings, Inc.
CEROW- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001870404
No open-market purchases or sales by Cero Therapeutics Holdings, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $4 in total; no superinvestor holds it.
Other share classesCERO
13F holders, Q3 2025
Institutional positions in Cero Therapeutics Holdings, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +1 vs. Q2 2025
- Shares held
- 2.84M
- +96.9K (+3.5%) vs. Q2 2025
- Total value
- $38.1K
- −$25.4K (−40.0%) vs. Q2 2025
- New holders
- 2
- 1 more added
- Sold out
- 1
- 2 more reduced
2 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CEROW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $4 |
| Q1 2026 | 1 | $11 |
| Q4 2025 | 1 | $22 |
| Q3 2025 | 22 | $38.1K |
| Q2 2025 | 23 | $74.5K |
| Q1 2025 | 26 | $45.7K |
| Q4 2024 | 27 | $28.6K |
| Q3 2024 | 31 | $28.0K |
| Q2 2024 | 35 | $110.3K |
| Q1 2024 | 38 | $425.3K |
| Q4 2023 | 41 | $135.1K |
| Q3 2023 | 44 | $423.7K |
| Q2 2023 | 44 | $351.0K |
| Q1 2023 | 47 | $234.9K |
| Q4 2022 | 50 | $264.8K |
| Q3 2022 | 44 | $503.0K |
| Q2 2022 | 42 | $550.0K |
| Q1 2022 | 36 | $1.02M |
| Q4 2021 | 31 | $1.35M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Cero Therapeutics Holdings, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Virtu Financial LLC | 21,104 | $0 | 0.00% | +630+3.1% | Added |
| Ancora Advisors, LLC | 2,500 | $33 | 0.00% | 00.0% | Unchanged |
| Fortress Financial Solutions, LLC | 10,000 | $133 | 0.00% | 00.0% | Unchanged |
| Silver Rock Financial LP | 12,224 | $163 | 0.00% | 00.0% | Unchanged |
| DuPont Capital Management Corp | 12,500 | $166 | 0.00% | 00.0% | Unchanged |
| Calamos Advisors LLC | 12,500 | $166 | 0.00% | 00.0% | Unchanged |
| Whitebox Advisors LLC | 23,250 | $309 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 27,500 | $366 | 0.00% | −22,500−45.0% | Reduced |
| Wolverine Asset Management LLC | 33,796 | $449 | 0.00% | 00.0% | Unchanged |
| Tenor Capital Management Co., L.P. | 50,000 | $665 | 0.00% | 00.0% | Unchanged |
| Westchester Capital Management, LLC | 74,998 | $997 | 0.00% | 00.0% | Unchanged |
| Picton Mahoney Asset Management | 75,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 98,468 | $1.31K | 0.00% | +98,468 | New |
| Highland Capital Management Fund Advisors, L.P. | 108,741 | $1.45K | 0.00% | 00.0% | Unchanged |
| Context Capital Management, LLC | 122,013 | $1.62K | 0.00% | 00.0% | Unchanged |
| Q Global Advisors, LLC | 170,785 | $2.00K | 0.00% | 00.0% | Unchanged |
| Blue Owl Capital Holdings LP | 224,930 | $2.99K | 0.00% | 00.0% | Unchanged |
| Linden Advisors LP | 249,999 | $3.60K | 0.00% | 00.0% | Unchanged |
| Saba Capital Management, L.P. | 295,913 | $4.26K | 0.00% | 00.0% | Unchanged |
| MMCAP International Inc. SPC | 375,000 | $4.99K | 0.00% | 00.0% | Unchanged |
| Toronto Dominion Bank | 381,018 | $5.33K | 0.00% | −300−0.1% | Reduced |
| Clear Street Group Inc. | 461,653 | $6.14K | 0.00% | +461,653 | New |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −441,048−100.0% | Sold out |
| Clear Street Derivatives LLC | – | – | – | – | Not filed |
| Clear Street LLC | – | – | – | – | Not filed |